Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Lifted by Tempus Wealth Planning LLC

Tempus Wealth Planning LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 16.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,348 shares of the company’s stock after buying an additional 741 shares during the quarter. Tempus Wealth Planning LLC’s holdings in Henry Schein were worth $390,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of HSIC. Swedbank AB acquired a new stake in shares of Henry Schein in the first quarter valued at $215,998,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Henry Schein in the second quarter valued at $46,683,000. SG Americas Securities LLC lifted its holdings in shares of Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock valued at $33,449,000 after buying an additional 432,187 shares during the period. Nuance Investments LLC lifted its holdings in shares of Henry Schein by 28.5% in the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after buying an additional 388,843 shares during the period. Finally, Magnetar Financial LLC lifted its holdings in shares of Henry Schein by 229.9% in the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock valued at $29,185,000 after buying an additional 269,330 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.14% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on HSIC. UBS Group reduced their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. reduced their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a report on Friday, September 20th. Robert W. Baird reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $77.50.

Henry Schein Stock Performance

Shares of HSIC stock opened at $71.19 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The stock’s 50-day moving average is $70.50 and its two-hundred day moving average is $69.83. The firm has a market cap of $9.12 billion, a P/E ratio of 24.05, a PEG ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The business’s revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.31 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.